Aldevron, a Danaher company and global leader in the production of DNA, RNA and protein for genomic medicine, and Minaris, a global cell and gene therapy contract development and manufacturing ...

Viral vectors are key delivery tools for advanced therapies, enabling gene transfer to treat inherited disorders, cancer and other serious diseases. Despite rapid clinical progress, manufacturing ...

The EvoLVcell stable producer cell line generation platform reportedly reduces variability and produces fewer impurities.

Throughout this three-part webinar series, experts from USP and industry will share first-hand experiences, case studies, and ...

Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve vector quality, and low batch variability. San Sebastián, Spain, May ...

Andelyn Biosciences, a leading cell and gene therapy Contract Development and Manufacturing Organization (CDMO), today announced it has received full certification under the Initiative for ...

The design of short LAM-PCR amplicons that do not exceed several hundred base pairs is critical for the efficiency of each analysis. Amplicons should be long enough to be resolved by electropheresis ...

T and gene therapies, ProBio Inc. and Curocell have achieved a significant milestone with the BLA regulatory approval and commercial readiness of Anbalcabtagene autoleucel (Anbal-cel; code: CRC01).

Orphan Therapeutics Accelerator (OTXL) , a non-profit biotech focused on completing development and enabling commercial access to stalled rare disease treatments, today announced that AGC Biologics, a ...

Collaboration brings AGC Biologics' advanced therapy expertise and global footprint to OTXL's network, supporting a sustainable path from clinical development to commercial access for therapies servin ...

BACKGROUND: Pulmonary hypertension (PH) is a serious complication of heart failure with preserved ejection fraction (HFpEF), ...